Eli Lilly and Company (LLY)
Eli Lilly's Weight-Loss Drugs Drove Its Stock Higher This Year. A New Plant in Alabama Could Boost Production
With demand for weight-loss drugs soaring and an agreement with the White House to produce more medicine in the U.S., Eli Lilly (LLY) is taking steps to boost its domestic output.
Abivax stock pops on Eli Lilly takeover speculation
Abivax SA (NASDAQ:ABVX, EPA:ABVX), a French biotechnology firm, saw its US-listed shares jump more than 11% on rumors it may be acquired by Eli Lilly and Co (NYSE:LLY). First reported by Reuters, neither Abivax nor Eli Lilly have confirmed the reports.
Eli Lilly to Build $6 Billion Alabama Plant as Part of U.S. Investment
The site is the third of four new facilities in the U.S. that the pharmaceutical company plans to announce, Eli Lilly said.
Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
Eli Lilly said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S. production and bolster medicine supply chains.
Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs
Eli Lilly said it will spend $6 billion to build a manufacturing plant in Huntsville, Alabama, to help boost production of its closely watched experimental obesity pill, orforglipron, and other drugs. It is the third facility in a string of new planned U.S. investments by the drugmaker.
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Lilly (LLY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Why Eli Lilly (LLY) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Eli Lilly's Mounjaro added to China's state insurance list for diabetes treatment
Eli Lilly's popular drug Mounjaro will be added to China's state-run health insurance scheme from January 1 for patients with type 2 diabetes, the National Healthcare Security Administration said in a website notice on Sunday.
Eli Lilly and Company (LLY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Eli Lilly and Company (LLY) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
LLY Lowers Prices of Zepbound Vials for Cash Buyers on DTC Website
Eli Lilly trims Zepbound vial prices on LillyDirect, offering lower monthly costs for self-paying patients across multiple doses.
Eli Lilly cuts price of Zepbound in heightened weight-loss drug competition
Eli Lilly and Co (NYSE:LLY) said on Monday it is lowering the cash prices of its weight-loss drug Zepbound, marking the latest move in a growing price battle with rival Novo Nordisk. The US pharmaceutical giant said single-dose vials of Zepbound will now be available on its direct-to-consumer platform, LillyDirect, at reduced prices.
Eli Lilly cuts Zepbound price to widen access for obesity drug
Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as demand for weight-loss therapies surge.
